Robert B Ford is CHAIRMAN AND CEO of ABBOTT LABORATORIES. Currently has a direct ownership of 220,059 shares of ABT, which is worth approximately $25.1 Million. The most recent transaction as insider was on Sep 12, 2024, when has been sold 141,679 shares (Common shares without par value) at a price of $116.47 per share, resulting in proceeds of $16,501,353. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 220K
0% 3M change
21.35% 12M change
Total Value Held $25.1 Million

Robert B Ford Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 12 2024
SELL
Open market or private sale
$16,501,353 $116.47 p/Share
141,679 Reduced 39.17%
220,059 Common shares without ...
Sep 12 2024
BUY
Exercise of conversion of derivative security
$6,793,508 $47.95 p/Share
141,679 Added 28.14%
361,738 Common shares without ...
Feb 29 2024
SELL
Payment of exercise price or tax liability
$3,794,780 $120.05 p/Share
31,610 Reduced 12.56%
220,059 Common shares without ...
Feb 21 2024
BUY
Grant, award, or other acquisition
-
70,332 Added 21.84%
251,669 Common shares without ...
Feb 28 2023
SELL
Payment of exercise price or tax liability
$3,067,129 $99.77 p/Share
30,742 Reduced 14.5%
181,337 Common shares without ...
Feb 17 2023
BUY
Grant, award, or other acquisition
-
70,008 Added 24.82%
212,079 Common shares without ...
Aug 25 2022
SELL
Open market or private sale
$10,764,867 $105.1 p/Share
102,425 Reduced 41.89%
142,071 Common shares without ...
Aug 25 2022
BUY
Exercise of conversion of derivative security
$4,110,315 $40.13 p/Share
102,425 Added 29.52%
244,496 Common shares without ...
Mar 25 2022
SELL
Bona fide gift
-
33,414 Reduced 19.04%
142,071 Common shares without ...
Feb 28 2022
SELL
Payment of exercise price or tax liability
$3,253,535 $122.41 p/Share
26,579 Reduced 13.15%
175,485 Common shares without ...
Feb 18 2022
BUY
Grant, award, or other acquisition
-
73,992 Added 26.8%
202,064 Common shares without ...
Jun 25 2021
SELL
Bona fide gift
-
28,746 Reduced 18.33%
128,072 Common shares without ...
Feb 26 2021
SELL
Payment of exercise price or tax liability
$2,779,927 $121.58 p/Share
22,865 Reduced 12.73%
156,818 Common shares without ...
Feb 19 2021
BUY
Grant, award, or other acquisition
-
70,058 Added 28.05%
179,683 Common shares without ...
May 15 2020
SELL
Bona fide gift
-
20,918 Reduced 16.02%
109,625 Common shares without ...
Feb 28 2020
SELL
Payment of exercise price or tax liability
$1,317,563 $79.19 p/Share
16,638 Reduced 11.3%
130,543 Common shares without ...
Feb 21 2020
BUY
Grant, award, or other acquisition
-
64,124 Added 30.35%
147,181 Common shares without ...
Jun 06 2019
SELL
Bona fide gift
-
18,833 Reduced 18.48%
83,057 Common shares without ...
Feb 28 2019
SELL
Payment of exercise price or tax liability
$1,133,891 $77.23 p/Share
14,682 Reduced 12.59%
101,890 Common shares without ...
Feb 22 2019
BUY
Grant, award, or other acquisition
-
45,797 Added 28.21%
116,572 Common shares without ...
Jun 01 2018
SELL
Payment of exercise price or tax liability
$18,397 $61.53 p/Share
299 Reduced 0.42%
70,775 Common shares without ...
Mar 06 2018
SELL
Bona fide gift
-
15,280 Reduced 17.69%
71,074 Common shares without ...
Feb 28 2018
SELL
Payment of exercise price or tax liability
$649,157 $60.55 p/Share
10,721 Reduced 11.04%
86,354 Common shares without ...
Feb 16 2018
BUY
Grant, award, or other acquisition
-
44,909 Added 31.63%
97,075 Common shares without ...
Jan 30 2018
SELL
Open market or private sale
$2,684,482 $62.92 p/Share
42,665 Reduced 31.46%
92,968 Common shares without ...
RBF

Robert B Ford

CHAIRMAN AND CEO
Abbott Park, IL

Track Institutional and Insider Activities on ABT

Follow ABBOTT LABORATORIES and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABT shares.

Notify only if

Insider Trading

Get notified when an Abbott Laboratories insider buys or sells ABT shares.

Notify only if

News

Receive news related to ABBOTT LABORATORIES

Track Activities on ABT